Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.02 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |